Publication | Closed Access
Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab
36
Citations
35
References
2016
Year
Calprotectin showed the strongest correlation with measures of disease activity and may be better than S100A12 when evaluating disease activity in RA patients. More extensive studies are needed to further compare the predictive value of the S100 proteins relative to radiographic progression.
| Year | Citations | |
|---|---|---|
1988 | 19.8K | |
1990 | 7.7K | |
1995 | 6.1K | |
1990 | 3.1K | |
1965 | 1.7K | |
2012 | 1.3K | |
1999 | 1.2K | |
1996 | 1K | |
1989 | 564 | |
2004 | 277 |
Page 1
Page 1